Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic

24. juni 2021 opdateret af: Anna Stigsdotter Neely, Umeå University

Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic: A Feasibility Study

Dance as a treatment to support physical, cognitive and emotional functioning, has gained increased acceptance as a healthcare intervention for people with Parkinson's Disease (PD). The impact of the COVID-19 pandemic has been far reaching with devastating effects for at-risk populations. To find alternative and safe treatment delivery options during the pandemic has been of outmost importance.

This mixed-methods, feasibility study on digital for people with Parkinson's Disease aimed to investigate: (1) the feasibility and safety of a digital home-based dance intervention for people with PD; (2) change in self-reported quality of life, cognitive complaints, psychological health and fatigue; and (3) the experience of digital dance for people with PD.

Twenty-three participants partook in 10 weekly digital dance classes at home via zoom. Feasibility outcomes measures were administered at post-test. Pre-post changes in self-reported quality of life, cognitive complaints, psychological health and fatigue were measured, as well as the experience of digital dance via focus groups.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

33

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Sverige
      • Stockholm, Sverige
        • Balettakademien

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Self-reported diagnosis of Parkinson's Disease
  • Participant in Dance for PD at Balettakademien, Stockholm, Sweden

Exclusion Criteria:

  • None

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: digital dance for PD
Enhed: Digital dance for PD
The digital dance class was held via Zoom. The class was scheduled once a week for 60 min and consisted of 10 sessions. A professional, certified Dance for PD and experienced dance instructor was teaching the dance class. The dance classes followed the Dance for PD protocol yet was adjusted to fit the digital zoom format.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Feasibility outcome measures
Tidsramme: Assessed at post-test

The following feasibility outcome measures were assessed: (a) Technical and safety issues, (b) Compliance and motivation, (c) Self-assessed improvement in physical function, wellbeing and cognitive function and (d) The importance of dance as an artistic and creative activity.

Each feasibility outcome measure was assessed via a 5-point Likert scale ranging from (1=very unsatisfactory, 5=very satisfactory), (1=not motivated, 5=very motivated), (1=noticeable worsening, 5=noticeable improvement) or (1=not meaningful, 5=very meaningful). Furthermore, each feasibility outcome measure had an open-ended question connected to it in order to capture any details related that feasibility domain. Two open-ended questions regarding positive and negative aspects of digital dancing were also included.

For each feasibility outcome measure, a criterion of success was developed in order to judge the the success rate of these feasibility outcome measures.
Assessed at post-test

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Depression and anxiety
Tidsramme: 12 weeks (pretest - posttest)
Severity of depression and anxiety symptoms measured by Hospital Anxiety Depression scale Anxiety score: 0-21 higher score indicate more anxiety Depression score: 0-21 higher score indicate more depression
12 weeks (pretest - posttest)
Quality of life (QoL) Summary index
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39), Summary index: 0-100 higher scores indicate more problems.

Furthermore, scores on the following subscales were assessed:

  • Mobility score: 0-100 higher scores indicate more problems
  • Activity of Daily Living score: 0-100 higher scores indicate more problems
  • Emotional well being score: 0-100 higher scores indicate more problems
  • Stigma score: 0-100 higher scores indicate more problems
  • Social support score: 0-100 higher scores indicate more problems
  • Cognition score: 0-100 higher scores indicate more problems
  • Communication score: 0-100 higher scores indicate more problems
  • Bodily discomfort score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) - Bodily discomfort
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Bodily discomfort score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) Communication
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Communication score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) Cognition
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale:Cognition score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) Social support
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Social support score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) Stigma
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Stigma score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) Emotional well being
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Emotional well being score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) Activity of Daily Living
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Activity of Daily Living score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) - Mobility
Tidsramme: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale Mobility score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Fatigue
Tidsramme: 12 weeks (pretest - posttest)
Fatigue measured by Checklist Individual Strength Questionnaire (CIS). Total score: 20-140
12 weeks (pretest - posttest)
Subjective cognitive complaints
Tidsramme: 12 weeks (pretest - posttest)
Improvement on subjective memory complaints measured by Prospective Retrospective Memory Questionnaire (PRMQ). Total score: 16-80 higher scores indicate more cognitive complaints prospective score: 0-100 higher scores indicate more cognitive complaints retrospective score: 0-100 higher scores indicate more cognitive complaints short term score: 0-100 higher scores indicate more cognitive complaints long term score: 0-100 higher scores indicate more cognitive complaints self cued score: 0-100 higher scores indicate more cognitive complaints environmentally cued: 0-100 higher scores indicate more cognitive complaints
12 weeks (pretest - posttest)
Mental fatigue
Tidsramme: 12 weeks (pretest - posttest)
Two questions from the Mental Fatigue Scale were used to measure mental fatigue (item 3) and recovery (item 4). Answers were given on a 7-point Likert scale.
12 weeks (pretest - posttest)
Experience and meaning of digital dance for people with PD
Tidsramme: Assessed at post-test
Two focus group interviews were conducted to examine the broader experience of digital dance for people with PD.
Assessed at post-test

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Age
Tidsramme: Assessed at pre-test
Demographic characteristic: age at baseline
Assessed at pre-test
Sex
Tidsramme: Assessed at pre-test
Demographic characteristic: sex
Assessed at pre-test
Educational level
Tidsramme: Assessed at pre-test
Demographic characteristic: educational level
Assessed at pre-test
Previous experience of dance for Parkinson's Disease
Tidsramme: Assessed at pre-test
Demographic characteristic: previous experience of dance for PD
Assessed at pre-test
Self-evaluated health
Tidsramme: Assessed a pre-test
Demographic characteristic: self-evaluated health
Assessed a pre-test
Disease duration
Tidsramme: Assessed at pre-test
Demographic characteristic: self-reported year of PD diagnosis
Assessed at pre-test
Current participation in physical exercise
Tidsramme: Assessed at pre-test
Demographic characteristic: current participation in physical exercise
Assessed at pre-test

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Umeå University

Samarbejdspartnere

Karlstad University

Efterforskere

  • Ledende efterforsker: Anna S Neely, prof, Umeå University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

4. september 2020

Primær færdiggørelse (Faktiske)

3. december 2020

Studieafslutning (Faktiske)

3. december 2020

Datoer for studieregistrering

Først indsendt

23. juni 2021

Først indsendt, der opfyldte QC-kriterier

24. juni 2021

Først opslået (Faktiske)

28. juni 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

28. juni 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

24. juni 2021

Sidst verificeret

1. juni 2021

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 136/2019

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner